POSTER SESSION VI Wednesday, March 10, 2004   —  1:00 - 4:00 p.m. Exhibit Hall B and C PULMONARY PATHOLOGY 195 Clinico-Cytopathologic Features of Pulmonary Coccidioidomycosis: A Study of 52 Cases (1443) MT Padilla, MW Andres, RE Sobonya, AR Prasad - University of Arizona Health Sciences Center, Tucson, AZ; Southern Arizona VA, Tucson, AZ 196 Immunopathology of Early Stage SARS (Severe Acute Respiratory Syndrome) (1416) AE Fraire, DH Libraty, F Dizon, R Olveda, A Barrientos, N Gonzaga, BA Woda - University of Massachussetts Medical School, Worcester, MA; Research Institute of Tropical Medicine, Manila, Philippines 197 Expression of Heat Shock Proteins (HSPs), Inducible Nitric Oxide Synthase (iNOS), Cyclo-Oxygenase-2 (COX-2), Detoxyfying Enzymes, Caspase 3 and Caspase 9 in Acute Lung Injury (1419) AK Haque, CY Castro, TC Allen, AC Laga, DS Zander, R Barrios, G Ayala, DD Killen, PT Cagle - University of Texas Medical Branch, Galveston, TX; Baylor College of Medicine, Houston, TX; University of Texas at Houston Medical School, Houston, TX 198 Myofibroblast Phenotype in Usual Interstitial Pneumonia (UIP) and Other Fibrotic Lung Diseases (1410) AH Cermik, R Barrios, AC Laga, TC Allen, DS Zander, A Haque, G Ayala, PT Cagle - Baylor College of Medicine, Houston, TX; University of Texas-Houston Medical School, Houston, TX; University of Texas Medical Branch, Galveston, TX 199 HSP 47, HSP 70 and FGF-2 in Usual Interstitial Pneumonia (UIP) and Other Inflammatory Lung Diseases (1411) AH Cermik, R Barrios, AC Laga, TC Allen, DS Zander, A Haque, G Ayala, PT Cagle - Baylor College of Medicine, Houston, TX; University of Texas-Houston Medical School, Houston, TX; University of Texas Medical Branch, Galveston, TX 200 Expression of Glucocorticoid Receptors Alpha and Beta in Insterstitial Lung Diseases (1446) J Ramirez. L Pujols, A Xaubet, J Mujol, JA Cidlowski, C Picado - IDIBAPS. Hospital Clínic. Universitat de Barcelona., Barcelona, Spain; National Institute of Environmental Health Sciences, Research Triangle Park., NC 201 Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) Are Not Associated with Pathogenesis of Usual Interstitial Pneumonia (UIP) (1429) AC Laga, TC Allen, AH Cermik, J Hicks, D Killen, R Barrios, A Haque, DS Zander, PT Cagle - Baylor College of Medicine, Houston, TX; University of Texas-Houston Medical School, Houston, TX; University of Texas Medical Branch, Galveston, TX 202 Diagnostic Utility of Langerin (CD207) for Histological Diagnosis of Pulmonary Langerhans Cell Histiocytosis (1452) K Shilo, W-S Chu, SL Abbondanzo, TJ Franks, WD Travis - Armed Forces Institute of Pathology, Washington, DC 203 Pulmonary Capillary Hemangiomatosis (PCH): Results of Gene Expression Analysis (1404) AM Assaad, SM Kawut, SM Arcasoy, EB Rosenzweig, JR Sonett, AC Borczuk - College of Physicians and Surgeons, Columbia University, New York, NY 204 PulmonaryThoracotomy for Germ Cell Tumor (1447) B Reichwage, JA Brooks, K Kesler, RA Rhoades, OW Cummings - Indiana University School of Medicine, Indianapolis, IN 205 Evaluation of Lung Parenchymal Injury and Apoptosis of Respiratory Cells in Passive Smoking Exposed Rats (1428) KY Kwon, HR Jung, SY Kwon, HK Oh, YN Kang, SP Kim, KK Park, SS Lee - Keimyung University School of Medicine, Daegu, Korea 206 Modifications to Small Airways in Chronic Obstructive Pulmonary Disease (COPD) (1413) FSF Chu, L Buzatu, S Utokaparch, WM Elliott, D Ionescu, RM Cherniack, RM Rogers, FC Chiurba, HO Coxson, PD Pare, JC Hogg - The University of British Columbia, McDonald Research Laboratories/iCAPTURE Centre, Vancouver, BC, Canada; The National Jewish Research and Medical Center, Denver, CO; The University of Pittsburgh Medical Center, Pittsburgh 207 Survey of Epithelial, Fibrous and Sarcomatous Tumours in the Belgian Mesothelioma Registry (1445) M Praet, G Hermans, M Remmelinck, B Weynand, E Verbeken, J Van Goethem - University Hospital Gent, Gent, Belgium; Middelheim Hospital, Antwerpen, Belgium 208 Malignant (Diffuse) Mesothelioma with Heterologous Differentiation: A Study of 14 Cases (1436) AM Mahar, TA Sporn, VL Roggli - Duke University and Durham VA Medical Centers, Durham, NC 209 NCAM (CD56) Differentiates Reactive Mesothelial Hyperplasia (RMH) from Diffuse Malignant Mesothelioma (DMM) (1400) M Amrikachi, AC Laga, R Barrios, TC Allen, AC Cermik, D Killen, A Haque, DS Zander, A Nicholson, D Henderson, PT Cagle - Baylor College of Medicine, Houston, TX; University of Texas-Houston Medical School, Houston, TX; University of Texas Medical Branch, Houston, TX; Brompton Hospital, London, United Kingdom; Flinders University of South Australia, Adelaide, Australia 210 Utility of Monoclonal D2-40 in Diagnosing Malignant Mesothelioma (1412) AY Chu, LA Litzky, TL Pasha, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA 211 Absence of SV40 DNA and RNA in Human Pleural Mesotheliomas. High Risk of False Positive DNA Results with Use of Primers Prone To Amplify SV40 Sequences Present in Common Laboratory Plasmids (1435) F Lopez-Rios, PB Illei, V Rusch, MF Zakowski, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY 212 Immunoreactivity for WT1 (Wilms' Tumor) Protein Using Monoclonal Antibody Clone 6F-H2 Distinguishes Pleural Mesothelioma from Breast Adenocarcinoma (1408) MW Bennett, GS Pinkus, JL Pinkus, JM Corson - Brigham and Women's Hospital and Harvard Medical School, Boston, MA"